Nadja Andrade, Business Development Manager at TAAV, will be attending next Advanced Therapies Week (Phacilitate) in Miami!
We are excited to join this unmissable event taking place January 16-19, 2024 in Miami,
With +1,800 attendees, this four-day conference brings together industry experts in the advanced therapies field.
Nadja will attend to meet you and explore how TAAV en neDNA™ can help you with your rAAV manufacturing.
What is neDNA™?
neDNA™, TAAV-manufactured enzymatic DNA offers an alternative to plasmid that intends to be safer producing higher and faster yields at lower costs.
Looking forward to meeting you:
January 16-19, 2024